In this webinar, you will learn:
Platform production processes simplify process development and make it easier to scale-up effectively. Similarly, a platform analytical testing strategy reduces the time for assay development. We describe key considerations when building such an integrated platform for viral vectors, and propose near-term and future-state solutions.
David Loong, Ph.D
MilliporeSigma Associate Director, Novel Modalities
David Loong is the Associate Director, Novel Modalities APAC, Strategy Ops. Previously, David held roles as a senior Scientist in Biotech startups encompassing cell & gene therapy process development services, mAb discovery, and preclinical development. He also has an extensive track record providing contract research services as a Senior Research Scientist at AMRI Global, and as a product custodian for API GMP manufacturing at GSK. He holds a Ph.D. in Synthetic Organic Chemistry from the Australian National University and a BTech(Hons) from Massey University (NZ) specializing in chemistry and process engineering.
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.